Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gunjan L Shah

Showing results (31-40 of 130) with videos related to

Pageof 13
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2019
Immune Cytopenias after Ex Vivo CD34+-Selected Allogeneic Hematopoietic Cell TransplantationMichael Scordo, Meier Hsu, Ann A Jakubowski, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 15, 2015
Robust Vaccine Responses in Adult and Pediatric Cord Blood Transplantation Recipients Treated for Hematologic MalignanciesGunjan L Shah, Leyla Shune, Duncan Purtill, et al.
Transplantation and Cellular Therapy|October 14, 2021
Hematopoietic Cell Transplantation is Feasible in Patients with Prior COVID-19 InfectionNishi Shah, Parastoo B Dahi, Doris M Ponce, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 29, 2018
Early Fluid Overload Is Associated with an Increased Risk of Nonrelapse Mortality after Ex Vivo CD34-Selected Allogeneic Hematopoietic Cell TransplantationCarlos Rondon-Clavo, Michael Scordo, Patrick Hilden, et al.
Transplantation and Cellular Therapy|May 11, 2022
Evaluation of Melphalan Exposure in Lymphoma Patients Undergoing BEAM and Autologous Hematopoietic Cell TransplantationParastoo B Dahi, Andrew Lin, Michael Scordo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2022
Capture Rate of V(D)J Sequencing for Minimal Residual Disease Detection in Multiple MyelomaMalin Hultcrantz, Even H Rustad, Venkata Yellapantula, et al.
The Lancet. Haematology|January 22, 2021
Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort studyAkshay Sharma, Neel S Bhatt, Andrew St Martin, et al.
Blood Advances|July 23, 2024
Optimizing the post-CAR T monitoring period in recipients of axicabtagene ciloleucel, tisagenlecleucel, and lisocabtagene maraleucelNausheen Ahmed, William Wesson, Forat Lutfi, et al.
Cancer|August 7, 2025
Outpatient cytarabine consolidation in acute myeloid leukemia safely reduces hospitalization time and treatment costsHannah Burton, Leora Boussi, David Nemirovsky, et al.
Transplantation and Cellular Therapy|October 24, 2024
Shift from Widespread to Tailored Antifungal Prophylaxis in Lymphoma Patients Treated with CD19 CAR T Cell Therapy: Results from a Large Retrospective CohortGiovanna Melica, Alejandro Luna de Abia, Gunjan L Shah, et al.
Pageof 13

Showing results (31-40 of 130) with videos related to

Sort By:
Pageof 13
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2019
Immune Cytopenias after Ex Vivo CD34+-Selected Allogeneic Hematopoietic Cell TransplantationMichael Scordo, Meier Hsu, Ann A Jakubowski, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 15, 2015
Robust Vaccine Responses in Adult and Pediatric Cord Blood Transplantation Recipients Treated for Hematologic MalignanciesGunjan L Shah, Leyla Shune, Duncan Purtill, et al.
Transplantation and Cellular Therapy|October 14, 2021
Hematopoietic Cell Transplantation is Feasible in Patients with Prior COVID-19 InfectionNishi Shah, Parastoo B Dahi, Doris M Ponce, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 29, 2018
Early Fluid Overload Is Associated with an Increased Risk of Nonrelapse Mortality after Ex Vivo CD34-Selected Allogeneic Hematopoietic Cell TransplantationCarlos Rondon-Clavo, Michael Scordo, Patrick Hilden, et al.
Transplantation and Cellular Therapy|May 11, 2022
Evaluation of Melphalan Exposure in Lymphoma Patients Undergoing BEAM and Autologous Hematopoietic Cell TransplantationParastoo B Dahi, Andrew Lin, Michael Scordo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2022
Capture Rate of V(D)J Sequencing for Minimal Residual Disease Detection in Multiple MyelomaMalin Hultcrantz, Even H Rustad, Venkata Yellapantula, et al.
The Lancet. Haematology|January 22, 2021
Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort studyAkshay Sharma, Neel S Bhatt, Andrew St Martin, et al.
Blood Advances|July 23, 2024
Optimizing the post-CAR T monitoring period in recipients of axicabtagene ciloleucel, tisagenlecleucel, and lisocabtagene maraleucelNausheen Ahmed, William Wesson, Forat Lutfi, et al.
Cancer|August 7, 2025
Outpatient cytarabine consolidation in acute myeloid leukemia safely reduces hospitalization time and treatment costsHannah Burton, Leora Boussi, David Nemirovsky, et al.
Transplantation and Cellular Therapy|October 24, 2024
Shift from Widespread to Tailored Antifungal Prophylaxis in Lymphoma Patients Treated with CD19 CAR T Cell Therapy: Results from a Large Retrospective CohortGiovanna Melica, Alejandro Luna de Abia, Gunjan L Shah, et al.
Pageof 13